The effects of 65 perfume formulations (perfume oils, perfumes, eau de parfum, eau de toilette) on mitochondrial membrane potential (ΔΨm) and mitochondrial respiration have been investigated using a mitochondria-based assay for ΔΨm, termed Psi-Screen. All the perfume formulations tested are highly active in the Psi-Screen assay, and the major site of inhibition in all cases is NADH-ubiquinone reductase (Complex I). This is confirmed in studies on the inhibition of NADH oxidase and NADH-ubiquinone reductase. Some formulations also inhibit succinate oxidation at either Complex II or Complex III. Evidence for the inhibition of mitochondrial ATPase is presented, as well as for the induction of reactive oxygen species production by perfume inhibition of Complex I. Thus, perfume formulations are multiple inhibitor mixtures which inhibit multiple bioenergetic functions at high dilutions (103 to 7 × 104). The implications of these findings are discussed with respect to cell toxicity via necrosis and/or apoptosis. Twenty candidate fragrance chemicals were investigated and all inhibited Complex I (5 at < 35μM). Mass screening strategies and high-throughput screening assays are discussed.
SikkemaJ., de BontJ.A.M., & PoolmanB. (1995). Mechanisms of membrane toxicity of hydrocarbons. Microbiological Reviews59, 201–222.
2.
BickersD.R., CalowP., GreimH.A., HanifinJ.M., RogersA.E., SauratJ.H., Glenn SipesI., SmithR.L., & TagamiH. (2003). The safety assessment of fragrance chemicals. Regulatory Toxicology and Pharmacology37, 218–273.
3.
JohansenJ.D. (2003). Fragrance contact allergy: a clinical review. American Journal of Clinical Dermatology4, 789–798.
4.
BridgesB. (2002). Fragrance: emerging health and environmental concerns. Flavour and Fragrance Journal17, 361–371.
5.
UribeS., AlvarezR., & PeñaA. (1984). Effects of β-pinene, a nonsubstituted mono-terpene, on rat liver mitochondria. Pesticide Biochemistry and Physiology22, 43–50.
6.
UstaJ., KreydiyyehS., BajakianK., & Nakkash-ChmaisseH. (2002). In vitro effect of eugenol and cinnamaldehyde on membrane potential and respiratory chain complexes in rat liver mitochondria. Food and Chemical Toxicology40, 935–940.
7.
KaH., ParkH.J., JungH.J., ChoiJ.W., ChoK.S., HaJ., & LeeK.T. (2003). Cinnamaldehyde induces apoptosis by ROS-mediated mitochondrial permeability transition in human promyelocytic leukaemia HL-60 cells. Cancer Letters196, 143–152.
8.
DuchenM.R. (2004). Mitochondria in health and disease: perspectives on a new mitochondrial biology. Molecular Aspects of Medicine25, 365–451.
9.
LyJ.D., GrubbD.R., & LawenA. (2003). The mitochondrial membrane potential (deltapsi[m]) in apoptosis; an update. Apoptosis8, 115–128.
10.
MewesH.W., & RafaelJ. (1981). The 2-(dimethy-laminostyryl)-1-methylpyridinium cation as indicator of the mitochondrial membrane potential. FEBS Letters131, 7–10.
11.
GriffithsD.E., & UstaJ. (1988). Effects of trialkyllead compounds on mitochondrial membrane potential. In The Biological Alkylation of Heavy Elements (eds. CraigP.J., & GlockingF.G.), pp. 205–210. London, UK: Royal Society of Chemistry.
12.
GriffithsD.E., & ConnertonI. (1988). Effects of trialkyllead compounds on mitochondrial energy con-servation. Applied Organometallic Chemistry2, 177–180.
13.
GriffithsD.E. (1988). Psi-Screen, a new in vitro cytotoxicity assay. British Patent Application No. 888829291.
14.
HatefiY., HaavikA.G., & GriffithsD.E. (1962). Studies of the electron transport system. XL. Preparation and properties of mitochondrial DPNH-coenzyme Q reductase. Journal of Biological Chemistry237, 1676–80.
15.
SelwynM.J., DawsonA.P., StockdaleM., & GainsN. (1970). Chloride-hydroxide exchange across mitochondrial, erythrocyte and artificial membranes mediated by trialkyl- and triphenyltin compounds. European Journal of Biochemistry14, 120–126.
16.
HatefiY., & LesterR.L. (1958). Studies on the mechanism of oxidative phosphorylation. III. Phosphorylating particle types from beef heart. Biochimica et Biophysica Acta27, 83–88.
17.
Matsuno-YagiA., & HatefiY. (1985). Studies on the mechanism of oxidative phosphorylation: Catalytic site cooperativity in ATP synthesis. Journal of Biological Chemistry260, 14424–14427.
18.
JacobsE.E., JacobM., SanadiD.R., & BradleyL.B. (1956). Uncoupling of oxidative phosphorylation by cadmium ion. Journal of Biological Chemistry233, 147–156.
19.
UstaJ., & GriffithsD.E. (1992). Organotin-flavone complexes: A new class of fluorescent probes for F1F0ATPase. Biochemical and Biophysical Research Communications188, 365–371.
20.
HeinonenJ.K., & LahtiR.J. (1981). A new and convenient colorimetric determination of inorganic orthophosphate and its application to the assay of inorganic pyrophosphatase. Analytical Biochemistry113, 313–317.
21.
TakeshigeK., & MinakamiS. (1979). NADH- and NADPH-dependent formation of superoxide anions by bovine heart submitochondrial particles and NADH-ubiquinone reductase preparation. Biochemical Journal180, 129–135.
22.
FusiF., ValotiM., SgaragliG., & MurphyM.P. (1991). The interaction of antioxidants and structurally related compounds with mitochondrial oxidative phosphorylation. Methods and Findings in Experimental and Clinical Pharmacology13, 599–603.
23.
Anon. (2003). Directive 2003/15/EC of the European Parliament and of the Council of 27 Febuary 2003. Official Journal of the European UnionL66, 26–35.
24.
RastogiS.C., JohansenJ.D., & MenneT. (1996). Natural ingredients based cosmetics: Content of selected fragrance sensitisers. Contact Dermatitis34, 423–426.
25.
JohansenJ.D., RastogiS.C., & MenneT. (1996). Contact allergy to popular perfumes; assessed by patch test, use test and chemical analysis. British Journal of Dermatology135, 419–422.
26.
RastogiS.C., MenneT., & JohansenJ.D. (2003). The composition of fine fragrances is changing. Contact Dermatitis48, 130–132.
27.
Anon. (2003). Perfume products/fragrance ingredients. Report No. 50 of the State Laboratory of the Canton Basel City, 3 pp. Basel, Switzerland: Kantonales Laboratorium Basel-Stadt. Website http://www.kantonslabor-bs.ch
28.
TurrensJ.F., & BoverisA. (1980). Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria. Biochemical Journal191, 421–427.
29.
ChenQ., VasquezE.J., MoghaddasS., HoppelC.L., & LesnefskyE.J. (2003). Production of reactive oxygen species by mitochondria: Central role of Complex III. Journal of Biological Chemistry278, 36027–36030.
30.
St-PierreJ., BuckinghamJ.A., RoebuckS.J., & BrandM.D. (2002). Topology of superoxide production from different sites in the mitochondrial electron transport chain. Journal of Biological Chemistry277, 44784–44790.
31.
AggelerR., CoonsJ., TaylorS.W., GhoshS.S., GarciaJ.J., CapaldiR.A., & MarusichM.F. (2002). A functionally active human F1F0ATPase can be purified by immunocapture from heart tissue and fibroblast cell lines. Subunit structure and activity studies. Journal of Biological Chemistry277, 33906–33912.
32.
BlattnerJ.R., HeL., & LemastersJ.J. (2001). Screening assays for the mitochondrial permeability transition using a fluorescence multiwell plate reader. Analytical Biochemistry295, 220–226.
33.
BernardG., Gimenez-ArnauE., RastogiS.C., HeydornS., JohansenJ.D., MenneT., GoossensA., AndersenK., & LepoittevinJ.P. (2003). Contact allergy to oak moss: Search for sensitising molecules using combined bioassay-guided chemical fractionation, GC-MS and structure-activity relationship analysis. Archives of Dermatological Research295, 229–235.
34.
RastogiS.C., BossiR., JohansenJ.D., MenneT., BernardG., Gimenez-ArnauE., & LepoittevinJ.P. (2004). Content of oak moss allergens atranol and chloroatranol in perfumes and similar products. Contact Dermatitis50, 367–370.
35.
KempR.B., MeredithR.W., & GambleS.H. (1985). Toxicity of commercial products on cells in suspension culture: a possible screen for the Draize eye irritation test. Food and Chemical Toxicology23, 267–270.
36.
HirstJ., CarrollJ., FearnleyI.M., ShannonR.J., & WalkerJ.E. (2003). The nuclear encoded subunits of complex I from bovine heart mitochondria. Biochimica et Biophysica Acta1604, 135–150.
37.
BatandierC., LeverveX., & FontaineE. (2004). Opening of the mitochondrial permeability transition pore induces reactive oxygen species production at the level of the respiratory chain complex I. Journal of Biological Chemistry279, 17197–17204.
38.
TaylorE.R., HurrellF., ShannonR.J., LinT.K., HirstJ., & MurphyM.P. (2003). Reversible glutathionylation of complex I increases mitochondrial superoxide formation. Journal of Biological Chemistry278, 19603–19610.
39.
BeerS.M., TaylorE.R., BrownS.E., DahmC.C., CostaN.J., RunswickM.J., & MurphyM.P. (2004). Glutaredoxin 2 catalyses the reversible oxidation and glutathionylation of mitochondrial membrane thiol proteins: Implications for mitochondrial redox regulation and antioxidant defence. Journal of Biological Chemistry279, 47939–47951.
40.
EttoreA., AndreassiM., AnselmiC., NeriP., AndreassiL., & Di StephanoA. (2003). Involvement of oxidative stress in apoptosis induced by a mixture of isothiazolinones in normal keratinocytes. Journal of Investigative Dermatology121, 328–336.
41.
LessengerJ.E. (2001). Occupational acute anaphylactic reaction to assault by perfume spray in the face. Journal American Board of Family Practice14, 137–140.
42.
KumarP., Caradonna-GrahamV.M., GuptaS., CaiX., RaoP.N., & ThompsonJ. (1995). Inhalation challenge effects of perfume scent strips in patients with asthma. Annals of Allergy, Asthma & Immunology75, 429–433.
43.
MillqvistE., BengtssonU., & LowhagenO. (1999). Provocations with perfume in the eyes induce airway symptoms in patients with sensory hyperreactivity. Allergy54, 495–499.
44.
AndersonR.C., & AndersonJ.H. (1998). Acute toxic effects of fragrance products. Archives of Environmental Health53, 138–146.
45.
HastingsL., & EvansJ.E. (1991). Olfactory primary neurons as a route of entry for toxic agents into the CNS. Neurotoxicology12, 707–714.
46.
JennerP. (1998). Oxidative mechanisms in nigral cell death in Parkinson's disease. Movement Disorders13, 24–34.
47.
JhaN., JurmaO., LalliG., LiuY., PettusE.H., GreenamyreJ.T., LiuR.M., FormanH.J., & AndersenJ.K. (2000). Glutathione depletion in PC12 results in selective inhibition of mitochondrial complex I activity. Implications for Parkinson's disease. Journal of Biological Chemistry275, 26096–26101.
48.
BetarbetR., ShererT.B., MacKensieG., Garcia-OsunaM., PanovA.V., & GreenamyreJ.T. (2000). Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nature Neuroscience3, 1301–1306.
49.
ShererT.B., BetarbetR., StoutA.K., LundS., BaptistaM., PanovA.V., CooksonM.R., & GreenamyreJ.T. (2002). An in vitro model of Parkinson's disease: Linking mitochondrial impairment to altered synuclein metabolism and oxidative damage. The Journal of Neuroscience22, 7006–7015.
50.
LuckenbachT., & EpelD. (2005). Nitromusk and polycyclic musk compounds as long-term inhibitors of cellular xenobiotic defence systems mediated by multidrug transporters. Environmental Health Perspectives113, 17–24.
51.
YoshidaN., TakagiA., KitazawaH., KawakamiJ., & AdachiI. (2005). Inhibition of P-glycoprotein-mediated transport by extracts of monoterpenoids contained in Zanthoxyli fructus. Toxicology and Applied Pharmacology (Epub ahead of print, May 9).
